Redesign of glycopeptide antibiotics: Back to the future

ACS Chemical Biology

Volumn 7, Issue 5, 2012, Pages 797-804

  James, Robert C ^a   Pierce, Joshua G ^a   Okano, Akinori ^a   Xie, Jian ^a   Boger, Dale L ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORITAVANCIN; POLYPEPTIDE ANTIBIOTIC AGENT; TEICOPLANIN; TELAVANCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIAL INFECTION; BINDING SITE; CHEMICAL MODIFICATION; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; PRIORITY JOURNAL; REVIEW;

ANTI-BACTERIAL AGENTS; DRUG DESIGN; ENTEROCOCCUS; GLYCOPEPTIDES; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; METHICILLIN RESISTANCE; MODELS, MOLECULAR; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 84862094645     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb300007j     Document Type: Review

References (44)

1. Hamad, B. (2010) The antibiotic market Nat. Rev. Drug Discovery 9, 675-676
2. Parker, M. T. and Jevons, M. P. (1964) A survey of methicillin resistance in Staphylococcus aureus Postgrad. Med. J. 40, 170-178
3. McCormick, M. H., Stark, W. M., Pittenger, G. E., Pittenger, R. C., and McGuire, J. M. (1955-1956) Vancomycin, a new antibiotic. I. Chemical and biologic properties Antibiot. Annu. 606-611
4. Harris, C. M., Kopecka, H., and Harris, T. M. (1983) Vancomycin: structure and transformation to CDP-1 J. Am. Chem. Soc. 105, 6915-6922
5. Nagarajan, R., Ed. (1994) Glycopeptide Antibiotics, Marcel Dekker Inc., New York.
6. Walsh, C. T. and Fischbach, M. A. (2009) New ways to squash superbugs Sci. Am. 301, 44-51
7. Cooper, G. L. and Given, D. B. (1986) The development of vancomycin, in Vancomycin, A Comprehensive Review of 30 Years of Clinical Experience, pp 1-5, Park Row Publications, Indianapolis, IN.
8. Howden, B. P., Davies, J. K., Johnson, P. D., Stinear, T. P., and Grayson, M. L. (2010) Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin- intermediate strains: resistance mechanisms, laboratory detection, and clinical implications Clin. Microbiol. Rev. 23, 99-139
9. CDC Reminds clinical laboratories and healthcare infection preventionists of their role in the search and containment of vancomycin-resistant Staphylococcus aureus (VRSA), May 2010; http://www.cdc.gov/HAI/settings/lab/vrsa
10. Zhu, W., Murray, P. R., and Huskins, W. C. (2010) Dissemination of an Enterococcus Inc18-like VanA plasmid associated with vancomycin-resistant Staphylococcus aureus Antimicrob. Agents Chemother. 54, 4214-4320
11. Perkins, H. R. (1982) Vancomycin and related antibiotics Pharmacol. Ther. 16, 181-197 (Pubitemid 12017537)
12. Bugg, T. D. H., Wright, G. D., Dutka-Malen, S., Arthur, M., Courvalin, P., and Walsh, C. T. (1991) Molecular basis of vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA Biochemistry 30, 10408-10415
13. Healy, V. L., Lessard, I. A. D., Roper, D. I., Knox, J. R., and Walsh, C. T. (2000) Vancomycin resistance in enterococci: reprogramming of the d -Ala- d -Ala ligases in bacterial peptidoglycan biosynthesis Chem. Biol. 7, R109-R119
14. Koteva, K., Hong, H.-J., Wang, X. D., Nazi, I., Hughes, D., Naldrett, M. J., Buttner, M. J., and Wright, G. D. (2010) A vancomycin photoprobe identifies the histidine kinase VanSsc as a vancomycin receptor Nat. Chem. Biol. 6, 327-329
15. Hong, H.-J., Hutchings, M. I., and Buttner, M. J. (2008) Vancomycin resistance VanS/VanR two-component systems Adv. Exp. Med. Biol. 631, 200-213
16. Arthur, M. and Quintiliani, R., Jr. (2001) Regulation of VanA- and VanB-type glycopeptide resistance in enterococci Antimicrob. Agents Chemother. 45, 375-381 (Pubitemid 32105270)
17. Marshall, C. G., Lessard, I. A., Park, I., and Wright, G. D. (1998) Glycopeptide antibiotic resistance genes in glycopeptide-producing organisms Antimicrob. Agents Chemother. 42, 2215-2220 (Pubitemid 28420352)
18. Kahne, D., Leimkuhler, C., Lu, W., and Walsh, C. T. (2005) Glycopeptide and lipoglycopeptide antibiotics Chem. Rev. 105, 425-448 (Pubitemid 40356089)
19. Allen, N. E., Hobbs, J. N., Jr., and Nicas, T. I. (1996) Inhibition of peptidoglycan biosynthesis in vancomycin-susceptible and -resistant bacteria by a semisynthetic glycopeptide antibiotic Antimicrob. Agents Chemother. 40, 2356-2362 (Pubitemid 26328046)
20. Ge, M., Chen, Z., Onishi, H. R., Kohler, J., Silver, L. L., Kerns, R., Fukuzawa, S., Thompson, C., and Kahne, D. (1999) Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding d -Ala- d -Ala Science 284, 507-511 (Pubitemid 29289628)
21. Chen, L., Walker, D., Sun, B., Hu, Y., Walker, S., and Kahne, D. (2003) Vancomycin analogues active against VanA-resistant strains inhibit bacterial transglycosylase without binding substrate Proc. Natl. Acad. Sci. U.S.A. 100, 5658-5663 (Pubitemid 36576864)
22. Corey, G. R., Stryjewski, M. E., Weyenberg, W., Yasothan, U., and Kirkpatrick, P. (2009) Telavancin Nat. Rev. Drug Discovery 8, 929-930
23. Higgins, D. L., Chang, R., Debabov, D. V., Leung, J., Wu, T., Krause, K. M., Sandvik, E., Hubbard, J. M., Kaniga, K., Schmidt, D. E., Jr., Gao, Q., Cass, R. T., Karr, D. E., Benton, B. M., and Humphrey, P. P. (2005) Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus Antimicrob. Agents Chemother. 49, 1127-1134 (Pubitemid 40327734)
24. Nicas, T. I., Mullen, D. L., Flokowitsch, J. E., Preston, D. A., Snyder, N. J., Zweifel, M. J., Wilkie, S. C., Rodriguez, M. J., Thompson, R. C., and Cooper, R. D. (1996) Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci Antimicrob. Agents Chemother. 40, 2194-2199 (Pubitemid 26296272)
25. Allen, N. E. and Nicas, T. I. (2003) Mechanism of action of oritavancin and related glycopeptide antibiotics FEMS Microbiol. Rev. 26, 511-532 (Pubitemid 36187412)
26. Boger, D. L., Miyazaki, S., Kim, S. H., Wu, J. H., Loiseleur, O., and Castle, S. L. (1999) Diastereoselective total synthesis of the vancomycin aglycon with ordered atropisomer equilibrations J. Am. Chem. Soc. 121, 3226-3227 (Pubitemid 29189774)
27. Boger, D. L., Miyazaki, S., Kim, S. H., Wu, J. H., Castle, S. L., and Loiseleur, O. (1999) Total synthesis of the vancomycin aglycon J. Am. Chem. Soc. 121, 10004-10011
28. Boger, D. L., Kim, S. H., Miyazaki, S., Strittmatter, H., Weng, J.-H., Mori, Y., Rogel, O., Castle, S. L., and McAtee, J. J. (2000) Total synthesis of the teicoplanin aglycon J. Am. Chem. Soc. 122, 7416-7417
29. Boger, D. L., Kim, S. H., Mori, Y., Weng, J.-H., Rogel, O., Castle, S. L., and McAtee, J. J. (2001) First and second generation total synthesis of the teicoplanin aglycon J. Am. Chem. Soc. 123, 1862-1871 (Pubitemid 32200004)
30. Crowley, B. M., Mori, Y., McComas, C. C., Tang, D., and Boger, D. L. (2004) Total synthesis of the ristocetin aglycon J. Am. Chem. Soc. 126, 4310-4317 (Pubitemid 38453890)
31. Garfunkle, J., Kimball, F. S., Trzupek, J. D., Takazawa, S., Shimamura, H., Tomishima, M., and Boger, D. L. (2009) Total synthesis of chloropeptin II (complestatin) and chloropeptin I J. Am. Chem. Soc. 131, 16036-16038
32. Shimamura, H., Breazzano, S. P., Garfunkle, J., Kimball, F. S., Trzupek, J. D., and Boger, D. L. (2010) Total synthesis of complestatin: development of a Pd(0)-mediated indole annulation for macrocyclization J. Am. Chem. Soc. 132, 7776-7783
33. Breazzano, S. P. and Boger, D. L. (2011) Synthesis and stereochemical determination of complestatin A and B (neuroprotectin A and B) J. Am. Chem. Soc. 133, 18495-18502
34. Williams, D. H. and Bardsley, B. (1999) The vancomycin group of antibiotics and the fight against resistant bacteria Angew. Chem., Int. Ed. 38, 1172-1193
35. McComas, C. C., Crowley, B. M., and Boger, D. L. (2003) Partitioning the loss in vancomycin binding affinity for d -Ala- d -Lac into lost H-bond and repulsive lone pair contributions J. Am. Chem. Soc. 125, 9314-9315 (Pubitemid 36936049)
36. 4]vancomycin aglycon: reengineering vancomycin for dual d -Ala- d -Ala and d -Ala- d -Lac binding J. Am. Chem. Soc. 128, 2885-2892
37. Boger, D. L. and Brotherton, C. E. (1984) Total synthesis of azafluoranthene alkaloids: rufescine and imelutine J. Org. Chem. 49, 4050-4055
38. 4]vancomycin aglycon, and related key compounds: reengineering vancomycin for dual d -Ala- d -Ala and d -Ala- d -Lac binding J. Am. Chem. Soc. 134, 1284-1297
39. Xie, J., Pierce, J. G., James, R. C., Okano, A., and Boger, D. L. (2011) A redesigned vancomycin engineered for dual d -Ala- d -Ala and d -Ala- d -Ala binding exhibits potent antimicrobial activity against vancomycin-resistant bacteria J. Am. Chem. Soc. 133, 13946-13949
40. Wright, G. D. (2011) Molecular mechanisms of antibiotic resistance Chem. Commun. 47, 4055-4061
41. Walsh, T. R. and Howe, R. A. (2002) The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus Annu. Rev. Microbiol. 56, 657-675 (Pubitemid 35217470)
42. Courvalin, P. (2006) Vancomycin resistance in Gram-positive cocci Clin. Infect. Dis. 42, S25-S34
43. Hegstad, K., Mikalsen, T., Coque, T. M., Werner, G., and Sundsfjord, A. (2010) Mobile genetic elements and their contribution to the emergence of antimicrobial resistant Enterococcus faecalis and Enterococcus faecium Clin. Microbiol. Infect. 16, 541-554
44. Walker, S., Chen, L., Helm, J., Hu, Y., Rew, Y., Shin, D., and Boger, D. L. (2005) Chemistry and biology of ramoplanin: a lipoglycodepsipeptide with potent antibiotic activity Chem. Rev. 105, 449-476